BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24827072)

  • 1. Renal artery occlusion in autosomal dominant polycystic kidney disease.
    Sánchez M; Enríquez R; Sirvent AE; Millan I; de la Iglesia P; Amorós F
    Ren Fail; 2014 Aug; 36(7):1142-4. PubMed ID: 24827072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in autosomal dominant polycystic kidney disease: observational study in 207 patients with a mean follow-up of 107 months.
    De Almeida EA; Prata MM
    Rev Port Cardiol; 2007 Nov; 26(11):1173-82. PubMed ID: 18297839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two cases of autosomal dominant polycystic kidney diseases who presented bilateral enlarged kidneys and severe hypertension in the neonatal period].
    Wakaki H; Ikeda M; Hataya H; Ishikura K; Nakashima T; Oosako Y; Honda M
    Nihon Jinzo Gakkai Shi; 2004 Oct; 46(7):719-23. PubMed ID: 15570901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of QTc interval and global autonomic activity in autosomal dominant polycystic kidney disease and atherosclerotic renal artery stenosis hypertensive patients.
    Lai S; Perrotta AM; Bagordo D; Mazzaferro S; Menè P; Gigante A; Tinti F; Galani A; Cianci R
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6333-6338. PubMed ID: 34730214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two cases of autosomal dominant polycystic kidney disease treated with hemodialysis associated with polycystic liver complications related to the cause of death].
    Saima S; Suzuki Y; Yoshimoto K; Nakamura Y; Munakata A
    Nihon Jinzo Gakkai Shi; 1996 Jun; 38(6):278-84. PubMed ID: 8752971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic renal failure in a patient with Sotos syndrome due to autosomal dominant polycystic kidney disease.
    Cefle K; Yildiz A; Palanduz S; Ozturk S; Ozbey N; Kylyçaslan I; Colakoglu S; Balci C
    Int J Clin Pract; 2002 May; 56(4):316-8. PubMed ID: 12074220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population.
    Kelleher CL; McFann KK; Johnson AM; Schrier RW
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1029-34. PubMed ID: 15533729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrum.
    van Gulick JJ; Gevers TJ; van Keimpema L; Drenth JP
    Neth J Med; 2011 Sep; 69(9):367-71. PubMed ID: 21978978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
    Seeman T; Vondrichová H; Strízová J; Sikut M; Janda J; Schärer K
    Cas Lek Cesk; 1999 Mar; 138(6):178-84. PubMed ID: 10510532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Schrier RW
    J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal dominant policystic kidney disease, more than a renal disease.
    Torra R
    Minerva Endocrinol; 2014 Jun; 39(2):79-87. PubMed ID: 24736482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed diagnosis of primary aldosteronism in patients with autosomal dominant polycystic kidney diseases.
    Kao CC; Wu VC; Kuo CC; Lin YH; Hu YH; Tsai YC; Wu CH; Wu KD;
    J Renin Angiotensin Aldosterone Syst; 2013 Jun; 14(2):167-73. PubMed ID: 22791703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of autosomal dominant polycystic kidney disease presenting hepatic encephalopathy].
    Munemura C; Noguchi K; Yamamoto S; Murawaki Y; Uemasu J; Godai K
    Nihon Jinzo Gakkai Shi; 2005; 47(4):458-62. PubMed ID: 15971889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation of renal volume in autosomal dominant polycystic kidney disease and relevant clinical implications.
    Masoumi A; Elhassan E; Schrier RW
    Iran J Kidney Dis; 2011 Jan; 5(1):1-8. PubMed ID: 21189426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relation of hypertension, renal function and cardiovascular events in autosomal dominant polycystic kidney disease].
    Idrizi A; Barbullushi M; Strakosha A; Kodra S; Thereska N; Zaimi E; Gjyzari A; Petrela E
    G Ital Nefrol; 2007; 24(6):595-9. PubMed ID: 18278763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension in children with autosomal dominant polycystic kidney disease (ADPKD).
    Cadnapaphornchai MA
    Curr Hypertens Rev; 2013 Feb; 9(1):21-6. PubMed ID: 23971640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic subdural haematoma and arachnoid cyst in autosomal dominant polycystic kidney disease (ADPKD).
    Leung GK; Fan YW
    J Clin Neurosci; 2005 Sep; 12(7):817-9. PubMed ID: 16150597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A 30-year-old woman patient with reno-parenchymatous arterial hypertension].
    Estlinbaum T
    Praxis (Bern 1994); 2003 Feb; 92(6):244-6. PubMed ID: 12645388
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal transcatheter arterial embolization for autosomal dominant polycystic kidney disease: report of two cases.
    Masue N; Katoh S; Itoh S; Ehara H; Takahashi Y; Ishihara S; Deguchi T
    Hinyokika Kiyo; 2005 Nov; 51(11):741-5. PubMed ID: 16363706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.